Obesity and atrial fibrillation

Obesity Reviews

Volumn 14, Issue 11, 2013, Pages 929-938

  Abed, H S ^a   Wittert, G A ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Atrial fibrillation; Fibrosis; Obesity; Pericardial fat

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ANGIOTENSIN II; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COLLAGEN FIBRIL; CONNECTIVE TISSUE GROWTH FACTOR; DIGOXIN; ENDOTHELIN 2; FATTY ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTRA-ABDOMINAL VISCERAL FAT; MAMMALIAN TARGET OF RAPAMYCIN; PLATELET DERIVED GROWTH FACTOR; POTASSIUM CHANNEL; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

APOPTOSIS; CATHETER ABLATION; CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; FATTY ACID BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMPLANTED HEART PACEMAKER; INFLAMMATION; INSULIN RESISTANCE; MUSCLE CELL; OBESITY; QUALITY OF LIFE; REVIEW; SLEEP DISORDERED BREATHING;

ATRIAL FIBRILLATION; FIBROSIS; OBESITY; PERICARDIAL FAT;

ATRIAL FIBRILLATION; ATRIAL REMODELING; HEART ATRIA; HUMANS; OBESITY;

EID: 84885862854     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12056     Document Type: Review

References (107)

1. Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N Engl J Med 2007; 357: 370-379.
2. Fox CS, Gona P, Hoffmann U etal. Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation 2009; 119: 1586-1591.
3. Jain SH, Massaro JM, Hoffmann U etal. Cross-sectional associations between abdominal and thoracic adipose tissue compartments and adiponectin and resistin in the Framingham Heart Study. Diabetes Care 2009; 32: 903-908.
4. Mahabadi AA, Massaro JM, Rosito GA etal. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 2009; 30: 850-856.
5. Rosito GA, Massaro JM, Hoffmann U etal. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008; 117: 605-613.
6. Tadros TM, Massaro JM, Rosito GA etal. Pericardial fat volume correlates with inflammatory markers: the Framingham Heart Study. Obesity (Silver Spring) 2010; 18: 1039-1045.
7. Thanassoulis G, Massaro JM, Hoffmann U etal. Prevalence, distribution, and risk factor correlates of high pericardial and intrathoracic fat depots in the Framingham heart study. Circ Cardiovasc Imaging 2010; 3: 559-566.
8. Eckel RH. Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997; 96: 3248-3250.
9. Kenchaiah S, Evans JC, Levy D etal. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305-313.
10. Tedrow UB, Conen D, Ridker PM, etal. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study). J Am Coll Cardiol 2010; 55: 2319-2327.
11. Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997; 337: 1360-1369.
12. Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M, Zimetbaum P. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health 2006; 9: 348-356.
13. Stewart S, Murphy NF, Walker A, McGuire A, McMurray JJ. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart 2004; 90: 286-292.
14. Karjalainen J, Kujala UM, Kaprio J, Sarna S, Viitasalo M. Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ 1998; 316: 1784-1785.
15. Mont L, Elosua R, Brugada J. Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace 2009; 11: 11-17.
16. Fox CS, Parise H, D'Agostino RB, Sr., etal. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004; 291: 2851-2855.
17. Mann SA, Otway R, Guo G, etal. Epistatic effects of potassium channel variation on cardiac repolarization and atrial fibrillation risk. J Am Coll Cardiol 2012; 59: 1017-1025.
18. Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS. Atrial fibrillation and obesity-results of a meta-analysis. Am Heart J 2008; 155: 310-315.
19. Miyasaka Y, Barnes ME, Gersh BJ, etal. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-125.
20. Gami AS, Hodge DO, Herges RM, etal. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007; 49: 565-571.
21. Wang TJ, Parise H, Levy D, etal. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004; 292: 2471-2477.
22. Rosengren A, Hauptman PJ, Lappas G, Olsson L, Wilhelmsen L, Swedberg K. Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J 2009; 30: 1113-1120.
23. Watanabe H, Tanabe N, Watanabe T, etal. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 2008; 117: 1255-1260.
24. Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah AS, Habib RH. Obesity and risk of new-onset atrial fibrillation after cardiac surgery. Circulation 2005; 112: 3247-3255.
25. Karasoy D, Bo Jensen T, Hansen ML, etal. Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study. Europace 2013; 15: 781-786.
26. Kistler PM, Sanders P, Dodic M, etal. Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J 2006; 27: 3045-3056.
27. Kim SJ, Choisy SC, Barman P, etal. Atrial remodeling and the substrate for atrial fibrillation in rat hearts with elevated afterload. Circ Arrhythm Electrophysiol 2011; 4: 761-769.
28. Medi C, Kalman JM, Spence SJ, etal. Atrial electrical and structural changes associated with longstanding hypertension in humans: implications for the substrate for atrial fibrillation. J Cardiovasc Electrophysiol 2011; 22: 1317-1324.
29. Lambert E, Sari CI, Dawood T, etal. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 2010; 56: 351-358.
30. Sarzani R, Salvi F, Dessi-Fulgheri P, Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens 2008; 26: 831-843.
31. Messerli FH. Cardiovascular effects of obesity and hypertension. Lancet 1982; 1: 1165-1168.
32. Coronel R, Langerveld J, Boersma LV, etal. Left atrial pressure reduction for mitral stenosis reverses left atrial direction-dependent conduction abnormalities. Cardiovasc Res 2010; 85: 711-718.
33. Gami AS, Pressman G, Caples SM, etal. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004; 110: 364-367.
34. Latina JM, Estes N A, 3rd, Garlitski AC. The Relationship between Obstructive Sleep Apnea and Atrial Fibrillation: A Complex Interplay. Pulm Med 2013; 2013: 621736.
35. Yagmur J, Yetkin O, Cansel M, etal. Assessment of atrial electromechanical delay and influential factors in patients with obstructive sleep apnea. Sleep Breath 2012; 16: 83-88.
36. Iwasaki YK, Shi Y, Benito B, etal. Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea. Heart Rhythm 2012; 9: 1409-1416 e1.
37. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol 2005; 105: 315-318.
38. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82: 2N-9N.
39. Watanabe M, Yokoshiki H, Mitsuyama H, Mizukami K, Ono T, Tsutsui H. Conduction and refractory disorders in the diabetic atrium. Am J Physiol Heart Circ Physiol 2012; 303: H86-H95.
40. Kato T, Yamashita T, Sekiguchi A, etal. What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol 2006; 17: 890-894.
41. Kato T, Yamashita T, Sekiguchi A, etal. AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat. J Cardiovasc Electrophysiol 2008; 19: 415-420.
42. Raposeiras-Roubin S, Rodino-Janeiro BK, Grigorian-Shamagian L, etal. Evidence for a role of advanced glycation end products in atrial fibrillation. Int J Cardiol 2012; 157: 397-402.
43. Aviles RJ, Martin DO, Apperson-Hansen C etal. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006-3010.
44. Sharma SK, Agrawal S, Damodaran D etal. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 2011; 365: 2277-2286.
45. Ishii Y, Schuessler RB, Gaynor SL etal. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation 2005; 111: 2881-2888.
46. Mazurek T, Zhang L, Zalewski A etal. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460-2466.
47. Batal O, Schoenhagen P, Shao M etal. Left atrial epicardial adiposity and atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 230-236.
48. Shin SY, Yong HS, Lim HE etal. Total and interatrial epicardial adipose tissues are independently associated with left atrial remodeling in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2011; 22: 647-655.
49. Rudolph V, Andrie RP, Rudolph TK etal. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med 2010; 16: 470-474.
50. Imazio M, Brucato A, Ferrazzi P etal. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation 2011; 124: 2290-2295.
51. Al Chekakie MO, Welles CC, Metoyer R, etal. Pericardial fat is independently associated with human atrial fibrillation. J Am Coll Cardiol 2010; 56: 784-788.
52. Thanassoulis G, Massaro JM, O'Donnell CJ, etal. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol 2010; 3: 345-350.
53. Kankaanpaa M, Lehto HR, Parkka JP, etal. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 2006; 91: 4689-4695.
54. Szczepaniak LS, Dobbins RL, Metzger GJ, etal. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 2003; 49: 417-423.
55. Abed HS, Samuel CS, Lau DH, etal. Obesity results in progressive atrial structural and electrical remodeling: Implications for atrial fibrillation. Heart Rhythm 2013; 10: 90-100.
56. Rabkin SW. Epicardial fat: properties, function and relationship to obesity. Obes Rev 2007; 8: 253-261.
57. Marchington JM, Pond CM. Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. Int J Obes 1990; 14: 1013-1022.
58. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004; 114: 147-152.
59. Zhou YT, Grayburn P, Karim A, etal. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 2000; 97: 1784-1789.
60. Nakazato R, Rajani R, Cheng VY, etal. Weight change modulates epicardial fat burden: a 4-year serial study with non-contrast computed tomography. Atherosclerosis 2012; 220: 139-144.
61. Snel M, Jonker JT, Hammer S, etal. Long-term beneficial effect of a 16-week very low calorie diet on pericardial fat in obese type 2 diabetes mellitus patients. Obesity (Silver Spring) 2012; 20: 1572-1576.
62. Wong CX, Abed HS, Molaee P, etal. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol 2011; 57: 1745-1751.
63. Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J 2007; 153: 907-917.
64. Malavazos AE, Ermetici F, Coman C, Corsi MM, Morricone L, Ambrosi B. Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity. Int J Cardiol 2007; 121: 132-134.
65. Nakagawa H, Scherlag BJ, Patterson E, Ikeda A, Lockwood D, Jackman WM. Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation. Heart Rhythm 2009; 6: S26-S34.
66. Khawaja O, Bartz TM, Ix JH, etal. Plasma free fatty acids and risk of atrial fibrillation (from the Cardiovascular Health Study). Am J Cardiol 2012; 110: 212-216.
67. Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD. Targeting fatty acid and carbohydrate oxidation-a novel therapeutic intervention in the ischemic and failing heart. Biochim Biophys Acta 2011; 1813: 1333-1350.
68. Lam YY, Hatzinikolas G, Weir JM, etal. Insulin-stimulated glucose uptake and pathways regulating energy metabolism in skeletal muscle cells: the effects of subcutaneous and visceral fat, and long-chain saturated, n-3 and n-6 polyunsaturated fatty acids. Biochim Biophys Acta 2011; 1811: 468-475.
69. Mazumder PK, O'Neill BT, Roberts MW, etal. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 2004; 53: 2366-2374.
70. Hammer S, Snel M, Lamb HJ, etal. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol 2008; 52: 1006-1012.
71. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 1994; 89: 724-730.
72. Abhayaratna WP, Fatema K, Barnes ME, etal. Left atrial reservoir function as a potent marker for first atrial fibrillation or flutter in persons>or=65 years of age. Am J Cardiol 2008; 101: 1626-1629.
73. Munger TM, Dong YX, Masaki M, etal. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. J Am Coll Cardiol 2012; 60: 851-860.
74. Stritzke J, Markus MR, Duderstadt S, etal. The aging process of the heart: obesity is the main risk factor for left atrial enlargement during aging the MONICA/KORA (monitoring of trends and determinations in cardiovascular disease/cooperative research in the region of Augsburg) study. J Am Coll Cardiol 2009; 54: 1982-1989.
75. Tsang TS, Barnes ME, Miyasaka Y, etal. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J 2008; 29: 2227-2233.
76. Conen D, Glynn RJ, Sandhu RK, Tedrow UB, Albert CM. Risk factors for incident atrial fibrillation with and without left atrial enlargement in women. Int J Cardiol 2013. doi: 10.1016/j.ijcard.2012.12.060.
77. Nguyen BL, Fishbein MC, Chen LS, Chen PS, Masroor S. Histopathological substrate for chronic atrial fibrillation in humans. Heart Rhythm 2009; 6: 454-460.
78. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008; 51: 802-809.
79. Haissaguerre M, Jais P, Shah DC, etal. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666.
80. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002; 54: 361-379.
81. Oakes RS, Badger TJ, Kholmovski EG, etal. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 2009; 119: 1758-1767.
82. Everett THt, Olgin JE. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 2007; 4: S24-S27.
83. Camelliti P, Borg TK, Kohl P. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 2005; 65: 40-51.
84. Creemers EE, Pinto YM. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 2011; 89: 265-272.
85. Yeh YH, Kuo CT, Chan TH, etal. Transforming growth factor-beta and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes. Cardiovasc Res 2011; 91: 62-70.
86. Rosenkranz S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 2004; 63: 423-432.
87. Burstein B, Libby E, Calderone A, Nattel S. Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation 2008; 117: 1630-1641.
88. Liao CH, Akazawa H, Tamagawa M, etal. Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts. J Clin Invest 2010; 120: 242-253.
89. Yang Z, Krasnici N, Luscher TF. Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade. Circulation 1999; 100: 5-8.
90. Rodriguez-Vita J, Ruiz-Ortega M, Ruperez M, etal. Endothelin-1, via ETA receptor and independently of transforming growth factor-beta, increases the connective tissue growth factor in vascular smooth muscle cells. Circ Res 2005; 97: 125-134.
91. Mayyas F, Niebauer M, Zurick A, etal. Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease. Circ Arrhythm Electrophysiol 2010; 3: 369-379.
92. Stein M, Boulaksil M, Jansen JA, etal. Reduction of fibrosis-related arrhythmias by chronic renin-angiotensin-aldosterone system inhibitors in an aged mouse model. Am J Physiol Heart Circ Physiol 2010; 299: H310-H321.
93. Mohanty S, Mohanty P, Di Biase L, etal. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation. J Am Coll Cardiol 2012; 59: 1295-1301.
94. Cha YM, Friedman PA, Asirvatham SJ, etal. Catheter ablation for atrial fibrillation in patients with obesity. Circulation 2008; 117: 2583-2590.
95. Mohanty S, Mohanty P, Di Biase L, etal. Influence of body mass index on quality of life in atrial fibrillation patients undergoing catheter ablation. Heart Rhythm 2011; 8: 1847-1852.
96. Ector J, Dragusin O, Adriaenssens B, etal. Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation. J Am Coll Cardiol 2007; 50: 234-242.
97. Guijian L, Jinchuan Y, Rongzeng D, Jun Q, Jun W, Wenqing Z. Impact of Body Mass Index on Atrial Fibrillation Recurrence: A Meta-analysis of Observational Studies. Pacing Clin Electrophysiol 2013; 36: 748-756.
98. Shoemaker MB, Muhammad R, Farrell M, etal. Relation of morbid obesity and female gender to risk of procedural complications in patients undergoing atrial fibrillation ablation. Am J Cardiol 2013; 111: 368-373.
99. Menezes AR, Lavie CJ, Dinicolantonio JJ, etal. Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies. Mayo Clin Proc 2013; 88: 394-409.
100. Abed HS, Wittert GA, Middeldorp ME, etal. Weight and Risk Factor Modification: Impact on Atrial Fibrillation. Circulation 2012; 126: 196-197.
101. Kanasaki K, Koya D. Biology of obesity: lessons from animal models of obesity. J Biomed Biotechnol 2011; 2011: 197636.
102. McCann JP, Bergman EN, Beermann DH. Dynamic and static phases of severe dietary obesity in sheep: food intakes, endocrinology and carcass and organ chemical composition. J Nutr 1992; 122: 496-505.
103. Jongnarangsin K, Chugh A, Good E, etal. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2008; 19: 668-672.
104. Chilukuri K, Dalal D, Gadrey S, etal. A prospective study evaluating the role of obesity and obstructive sleep apnea for outcomes after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2010; 21: 521-525.
105. Kanagala R, Murali NS, Friedman PA, etal. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003; 107: 2589-2594.
106. Liu T, Li G, Li L, Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 2007; 49: 1642-1648.
107. Mainigi SK, Sauer WH, Cooper JM, etal. Incidence and predictors of very late recurrence of atrial fibrillation after ablation. J Cardiovasc Electrophysiol 2007; 18: 69-74.